Status:
COMPLETED
Effects of Auri Super Mushroom Daily Gummies on Cognitive Health
Lead Sponsor:
Auri Nutrition
Collaborating Sponsors:
Citruslabs
Conditions:
Cognitive Decline
Focus Deficit
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
This is a single-arm, open-label, virtual clinical trial evaluating the cognitive health effects of Auri Super Mushroom Daily Gummies in a population of 35 adult participants over 8 weeks. Participant...
Eligibility Criteria
Inclusion
- Be male or female
- Be aged 30+
- Anyone who has been experiencing issues consistently for the last four weeks regarding all of the following:
- Forgetfulness Inability to focus Low energy levels Low mood
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease
- Willing to stop any other products or any medication or supplements that target cognition or cognitive health for the study duration
- Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study
- Not undergone any surgeries or invasive treatments in the last six months
- Not had any major illness in the last three months
- Resides in the United States
- Not currently partaking in another research study and will not be partaking in any other research study for the next 8 weeks and at any point during this study's duration
- Willing to consult with their healthcare provider before enrolling in the study if taking any prescription medication
Exclusion
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone with any allergies or sensitivities to any of the study product ingredients
- Anyone taking immunosuppressants
- Anyone taking blood thinners (anticoagulants)
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
- Anyone unwilling to follow the study protocol
- Anyone with a history of substance abuse
- Anyone with intolerance or sensitivity to mushrooms
Key Trial Info
Start Date :
April 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT07198399
Start Date
April 3 2025
End Date
August 1 2025
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Las Vegas, Nevada, United States, 89118